Bohne, W., Hunter, C.A. , White, M.W., Ferguson, D.J.P., Gross, U. and Roos, D.S. (1998). Targeted disruption of the bradyzoite-specific gene bag1does not prevent tissue cyst formation in Toxoplasma gondii. Molecular Biochemical Parasitology 92: 291-301.

Coughlin, C.M., Salhany, K.E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A.E., Hunter, C.A. , Fox, J.C., Trinchieri, G., and Lee, W.M.F. (1998). Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. Journal Clinical Investigation 101:1441-1452.

Kurzawa, H., Hunter, C.A. , Wysocka, M., Trinchieri, G., and Lee. W.M.F. (1998). Immune suppression by recombinant IL-12 involves IFNg induction of nitric oxide synthase 2 (iNOS) activity: Inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. Journal Experimental Medicine 188:1603-1610.

Hodge-Dufour, J., Marino, M.W., Horton, M.R., Jungbluth, A., Burdick, M.D., Strieter, R.M., Noble, P.W., Hunter, C.A. , and PurÈ, E. (1998). Inhibition of interferon induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proceedings National Academy Sciences (USA) 95:13806-13811.

Li, J., Hunter, C.A. , and Farrell, J.P. (1999). Anti-TGF-b treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. Journal Immunology 162:974-979

Walker, W., Aste-Amezaga, M., Kastelein, R.A., Trinchieri, G., and Hunter, C.A. (1999). Interleukin (IL)-18 and CD28 uses distinct molecular mechanisms to enhance natural killer cell production of IL-12-induced interferon-gamma. Journal of Immunology 162: 5894-5901.

Alexander, J. and Hunter, C.A (1998) Immunoregulation during Toxoplasmosis. Chemical Immunology 70: 81-104 (In Immunology of Intracellular Parasites, Editors F.Y.Liew and F.E.G. Cox).

Villegas, E.N., Wille, U., Craig, L., Linsley, P.S., Rennick, D.M., Peach, R., Hunter, C.A. (2000). Blockade of costimulation prevents infection-induced immunopathology in
interleukin-10 deficient mice. Infection and Immunity 68:2837-2844.

Reichmann, G., Walker, W., Villegas, E.N., Craig, L., Cai, G., Alexander, J., Hunter, C.A. (2000) The CD40/CD40L interaction is required for resistance to toxoplasmic
encephalitis. Infection and Immunity 68:1312-1318.

Cai, G., Radzanowski, T., Villegas, E., Kastelein, R.A., Hunter, C.A. (2000). Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma
gondii. Journal of Immunology 165:2619-2627.

Cai, G., Kastelein, R.A., Hunter, C.A. (2000). Interleukin 18 enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infection and Immunity 68:6932-6938.
Caamano, J., Tato, C., Cai, G., Villegas, E., Speirs, K., Craig, L., Alexander, J., Hunter, C.A. (2000). Identification of a role for NF-kB2 in the regulation of apoptosis and in
maintenance of T cell-mediated immunity to Toxoplasma gondii. Journal of Immunology 165:5720-5728.

Blass, S.L., Pure, E., Hunter, C.A. (2001). A role for CD44 in the production of IFN-g and immunopathology during toxoplasmosis. Journal of Immunology 166: 5726-5733.

Hunter, C.A. , D.Yu, M.Gee, C.Ngo, C.Sevignani, S.Evans, T. Golovkina,
M.Goldschmidt, W.F. Lee, and A.Thomas-Tikhonenko (2001) Cutting Edge: Systemic inhibition of angiogenesis underlies resistance to tumors during infection. Journal of
Immunology 166: 5878-5881.

Villarino, A., Planz, L., Lieberman, L., Wilson, E., Yoshida, H., Mak, T., Kastelein, R., Saris, C. and Hunter, C.A. (2003). The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.

Pearce, E. L, Mullen, A. C., Martins, G. A., Krawczyk, C. M., Hutchins, A. S., Zediak, V. P., Banica, M., DiCioccio, C. B., Gross, D. A., Mao, C. A., Shen, H., Cereb, N., Yang, S. Y., Lindsten, T., Rossant, J., Hunter, C. A., Reiner, S. L. (2003). Control of effector CD8+ T cell function by the transcription factor Eomesodermin, Science 302: 1041-3

Mason, N.J.. Liou, H.C., Hunter, C.A. (2004). C-Rel plays a critical role in the regulation of T cell responses required for resistance to toxoplasmic encephalitis. Journal Immunology 172: 3704-3711

Tato, C.M., G. Martins, F.A. High, K. DiCoco, S.L. Reiner and C.A. Hunter. (2004) Cutting Edge: Early production of IFN-$B&C(B by NK cells is independent of epigenetic modification of the IFN-$B&C(B promoter. Journal Immunology 173:1514-1518.

Lieberman, L., Cardillo, F., Cua,D., Rennick, D., Kastelein, R., Hunter, C.A. (2004). IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12 Journal Immunology 173:1887-1893.

Artis, D.; Villarino, A.; Silverman, M.; He, W.; Thornton, E.M; Mu, S.; Summer, S.; Covey, T.; Huang, E.; Yoshida, H.; Koretzky, G.; Goldschmidt, M.; Wu, G.D.; de Sauvage, F.; Millar, H.R.P.; Saris, C.; Scott, P.; Hunter, C.A. 2004. The IL-27R (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. Journal Immunology 173: 5626-34.

Pepper, M., Dzierszinski, F., Hunter, CA., Roos, D. (2004). Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infection and Immunity 72: 7240-6.

Immunology

Parsitology